• 

  Dementia’s Behavioral Changes: A Psychiatrist Explains
• 

  Leqembi Vs. Kisunla: An Alzheimer’s Drug Point-by-Point Comparison
• 

  NIH Activities Grind to Halt Under Trump Comms Freeze
• 

  The Science of Empathy Dolls: ‘Doll Therapy’ in Dementia Care
• 

  Menopause STUDY: How Does Hormone Replacement Therapy Impact Dementia Risk?
• 

  Some Trial Volunteers Had Higher Risk of Brain Bleeds. Here’s Why Drugmakers Didn’t Tell Them
• 

  VOICES: Preserving the Independence of Someone Living With Dementia
• 

  Axsome Asks FDA to Approve Questionable Alzheimer’s Agitation Drug
• 

  The Link Between Light Pollution and Alzheimer’s Risk
• 

  How a Condition Transmitted by Cannibalism Shed New Light on Brain Diseases
• 

  Are Psychedelics Good for the Brain? Dr. Gül Dölen is Using Octopuses to Find the Answers
• 

  Quebec Allows People to Break Federal Laws Around Dementia and Medical Euthanasia
• 

  Some Science Behind That ‘Reducing Screen Time’ New Year’s Resolution
• 

  Alzheimer’s Drugmaker Athira Shells Out $4 Million In DOJ Settlement
• 

  STUDY: Wildfire Smoke Exposure Ups Dementia Risk

Previous181920Next